Related Experiment Videos

Do antibiotic combinations prevent the emergence of resistant organisms?

W A Craig¹, F R Salamone

¹Wm. S. Middleton Memorial Veterans Hospital, Madison, WI 53705.

Infection Control and Hospital Epidemiology

|September 1, 1988

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Impact of MIC range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the ceftolozane in vivo pharmacokinetic/pharmacodynamic target.

Antimicrobial agents and chemotherapy·2014

In vivo activities of ceftolozane, a new cephalosporin, with and without tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, including strains with extended-spectrum β-lactamases, in the thighs of neutropenic mice.

Antimicrobial agents and chemotherapy·2013

In vivo pharmacodynamics of new lipopeptide MX-2401.

Antimicrobial agents and chemotherapy·2010

In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models.

Antimicrobial agents and chemotherapy·2008

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.

Antimicrobial agents and chemotherapy·2006

Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models.

Antimicrobial agents and chemotherapy·2005

See all related articles